The annual incidence of cholesteatoma is reported as 3 per 100,000 children and 9.2 per 100,000 adults.[4]Castle JT. Cholesteatoma pearls: practical points and update. Head Neck Pathol. 2018 Sep;12(3):419-29.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081285
http://www.ncbi.nlm.nih.gov/pubmed/30069838?tool=bestpractice.com
This varies both worldwide and with the population studied. Approximately 70% to 96% of cholesteatomas are acquired.[1]Kuo CL, Shiao AS, Yung M, et al. Updates and knowledge gaps in cholesteatoma research. Biomed Res Int. 2015;2015:854024.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381684
http://www.ncbi.nlm.nih.gov/pubmed/25866816?tool=bestpractice.com
Congenital cholesteatoma is much less common, with incidence estimated at 0.12 per 100,000.[6]Walker D, Shinners MJ. Congenital cholesteatoma. Pediatr Ann. 2016 May 1;45(5):e167-70.
http://www.ncbi.nlm.nih.gov/pubmed/27171804?tool=bestpractice.com
Incidence may be affected by medical practice. The use of grommets or aural ventilation tubes in patients with chronic otitis media was associated with a fall in the incidence of cholesteatoma surgery in Finland and Israel.[7]Rakover Y, Keywan K, Rosen G. Comparison of the incidence of cholesteatoma surgery before and after using ventilation tubes for secretory otitis media. Int J Pediatr Otorhinolaryngol. 2000 Nov 30;56(1):41-4.
http://www.ncbi.nlm.nih.gov/pubmed/11074114?tool=bestpractice.com
[8]Kemppainen HO, Puhakka HJ, Laippala PJ, et al. Epidemiology and aetiology of middle ear cholesteatoma. Acta Otolaryngol. 1999;119(5):568-72.
http://www.ncbi.nlm.nih.gov/pubmed/10478597?tool=bestpractice.com
However, no change was noted in the incidence of disease in Scotland and Ireland, with these treatments.[9]Padgham N, Mills R, Christmas H. Has the increasing use of grommets influenced the frequency of surgery for cholesteatoma? J Laryngol Otol. 1989 Nov;103(11):1034-5.
http://www.ncbi.nlm.nih.gov/pubmed/2607198?tool=bestpractice.com
[10]Kinsella JB. Ventilation tubes and cholesteatoma. 1996 Nov-Dec;89(6):223.
http://www.ncbi.nlm.nih.gov/pubmed/8996953?tool=bestpractice.com
There are fewer data on prevalence, but in Jerusalem it has been quoted as high as 70 per 100,000 children.[11]Cohen D, Tamir D. The prevalence of middle ear pathologies in Jerusalem school children. Am J Otol. 1989 Nov;10(6):456-9.
http://www.ncbi.nlm.nih.gov/pubmed/2610232?tool=bestpractice.com
In Australian Aboriginal children, a prevalence of 50 per 100,000 in a study of 7362 ears has been reported.[12]McCafferty GJ, Coman WB, Shaw E, et al. Cholesteatoma in Australian aboriginal children. In: Cholesteatoma: first international conference. Birmingham AL: Aesculapius Publishing Company; 1975:293-301. Prevalence has been shown to vary according to race; it is highest among white Americans, followed by Africans, whereas it is rarely observed in non-Indian Asians. Prevalence is higher in under-developed countries than in developed countries; however, no difference has been observed among different socio-economic groups.[1]Kuo CL, Shiao AS, Yung M, et al. Updates and knowledge gaps in cholesteatoma research. Biomed Res Int. 2015;2015:854024.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381684
http://www.ncbi.nlm.nih.gov/pubmed/25866816?tool=bestpractice.com
One Swedish case-control study using nationwide register data found that the risk of cholesteatoma was strongly associated with a family history of the condition, suggesting a possible genetic pre-disposition; family history was nevertheless quite rare and could therefore only explain a limited number of all cases.[13]Bonnard Å, Engmér Berglin C, Wincent J, et al. The risk of cholesteatoma in individuals with first-degree relatives surgically treated for the disease. JAMA Otolaryngol Head Neck Surg. 2023 May 1;149(5):390-6.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020932
http://www.ncbi.nlm.nih.gov/pubmed/36929420?tool=bestpractice.com
Males slightly outnumber females, with a ratio of 1.4:1. Among children, a 72% preponderance of boys has been reported.[1]Kuo CL, Shiao AS, Yung M, et al. Updates and knowledge gaps in cholesteatoma research. Biomed Res Int. 2015;2015:854024.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381684
http://www.ncbi.nlm.nih.gov/pubmed/25866816?tool=bestpractice.com
In the paediatric population, cholesteatomas account for 10% of chronic otitis media cases. The mean age of children with acquired cholesteatoma has been estimated at 9.7 years. Approximately 7% to 10% of affected children have simultaneous bilateral cholesteatomas or develop subsequent contralateral cholesteatomas during follow-up; both of these conditions are more common in girls. It has been proposed that children with craniofacial syndromes are predisposed to develop cholesteatoma; an estimated 0.9% to 5.9% of children with a cleft palate develop primary acquired cholesteatoma.[1]Kuo CL, Shiao AS, Yung M, et al. Updates and knowledge gaps in cholesteatoma research. Biomed Res Int. 2015;2015:854024.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381684
http://www.ncbi.nlm.nih.gov/pubmed/25866816?tool=bestpractice.com
Cholesteatoma in children has been found to affect the eustachian tube, anterior mesotympanum, retrolabyrinthine cells, and mastoid tip more than in adults. Clinical and histological evidence suggests that cholesteatoma in children tends to be more aggressive.[14]Nevoux J, Lenoir M, Roger G, et al. Childhood cholesteatoma. Eur Ann Otorhinolaryngol Head Neck Dis. 2010 Sep;127(4):143-50.
http://www.ncbi.nlm.nih.gov/pubmed/20860924?tool=bestpractice.com